To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer (NCT05772377) | The First Affiliated Hospital with Nanjing Medical University | 2023-07-01 |
Track To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer automatically
Every clearance here is in the API, with alerts when new ones post.